NEW DELHI: A day after its deal with American vaccine developer Novavax, Pune-based Serum Institute of India (SII) has tied up with Gavi, The Vaccine Alliance and Bill and Melinda Gates Foundation to accelerate the manufacture and delivery of up to 10 crore doses of COVID-19 vaccines for India and other low income countries by 2021, reported Money Control.
A day after its deal with American vaccine developer Novavax, Pune-based Serum Institute of India (SII) has tied up with Gavi, The Vaccine Alliance and Bill and Melinda Gates Foundation to accelerate the manufacture and delivery of up to 10 crore doses of COVID-19 vaccines for India and other low income countries by 2021.
Poonawalla’s SII has also entered a licence and supply agreement for the development and commercialisation of Novavax’ COVID‑19 vaccine candidate in India and other low- and middle-income countries. The deal was signed on July 30, according to a Securities and Exchange Commission filing by Novavax.
Read more: Money Control
